Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 8 | 2022 | 534 | 1.190 |
Why?
|
| Cachexia | 3 | 2022 | 53 | 0.930 |
Why?
|
| Cation Transport Proteins | 4 | 2021 | 60 | 0.910 |
Why?
|
| Cell Culture Techniques | 2 | 2020 | 116 | 0.740 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2019 | 7 | 0.620 |
Why?
|
| Osteoclasts | 1 | 2019 | 29 | 0.610 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 33 | 0.590 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 42 | 0.580 |
Why?
|
| Cell Differentiation | 1 | 2019 | 407 | 0.510 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 3 | 2021 | 26 | 0.480 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 1324 | 0.310 |
Why?
|
| Mice | 9 | 2022 | 4645 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 464 | 0.270 |
Why?
|
| Animals | 9 | 2022 | 10399 | 0.220 |
Why?
|
| Integrin alpha3 | 2 | 2021 | 18 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2021 | 135 | 0.200 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2021 | 115 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 179 | 0.200 |
Why?
|
| Acetate-CoA Ligase | 1 | 2022 | 9 | 0.200 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 39 | 0.190 |
Why?
|
| Cell Movement | 2 | 2021 | 369 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 270 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 79 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2019 | 330 | 0.180 |
Why?
|
| Cell Plasticity | 1 | 2021 | 10 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2022 | 295 | 0.180 |
Why?
|
| Adenosine | 1 | 2021 | 33 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 156 | 0.180 |
Why?
|
| Organoids | 1 | 2020 | 22 | 0.180 |
Why?
|
| Zinc | 1 | 2021 | 59 | 0.170 |
Why?
|
| Integrin beta1 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 48 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 162 | 0.160 |
Why?
|
| Glioma | 1 | 2020 | 118 | 0.160 |
Why?
|
| Deoxycytidine | 1 | 2019 | 66 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2019 | 9 | 0.160 |
Why?
|
| RANK Ligand | 1 | 2019 | 19 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 21 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 45 | 0.150 |
Why?
|
| Random Allocation | 1 | 2018 | 151 | 0.150 |
Why?
|
| Reference Values | 1 | 2018 | 200 | 0.150 |
Why?
|
| Claudin-1 | 1 | 2018 | 7 | 0.150 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2018 | 17 | 0.150 |
Why?
|
| Pancreatectomy | 1 | 2018 | 58 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 167 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 194 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 413 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 521 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2021 | 522 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 297 | 0.130 |
Why?
|
| Humans | 10 | 2022 | 28121 | 0.120 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2015 | 3 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 31 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2015 | 161 | 0.110 |
Why?
|
| Heterografts | 3 | 2020 | 66 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 633 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2015 | 105 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2022 | 804 | 0.100 |
Why?
|
| Muscles | 2 | 2022 | 73 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 301 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 226 | 0.080 |
Why?
|
| Spheroids, Cellular | 2 | 2021 | 54 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 162 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2021 | 1433 | 0.080 |
Why?
|
| Dynamin II | 1 | 2022 | 13 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 21 | 0.050 |
Why?
|
| Dextrans | 1 | 2022 | 23 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2022 | 42 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2022 | 38 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 38 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 208 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 95 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 141 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 58 | 0.040 |
Why?
|
| Male | 3 | 2021 | 13487 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 190 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 289 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 142 | 0.040 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 15 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 33 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 255 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2019 | 58 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 90 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 158 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 454 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 98 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 134 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 179 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 430 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 575 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 803 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 462 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 478 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 402 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 473 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 465 | 0.030 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2015 | 13 | 0.030 |
Why?
|
| Female | 2 | 2021 | 15156 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 318 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 510 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1461 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 7164 | 0.020 |
Why?
|